CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery solutions, is excited to announce that it’s received the BioIndustrial Innovation of the Year award by the BioTech ...
CHICAGO, January 29, 2025--(BUSINESS WIRE)--VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received ...
VectorBuilder today announced that its founder and chief scientist, Dr. Bruce Lahn, has been named to the prestigious “2024 Forbes China 100 Most Influential Chinese Selection.” This marks the fourth ...
CHICAGO--(BUSINESS WIRE)--Gene delivery technologies are turning into the next big-ticket item globally, as the most recent investment received by VectorBuilder Inc., a global leader in this field, ...
GUANGZHOU, China, Nov. 26, 2024 /PRNewswire/ -- VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the ...
VectorBuilder Inc. – a global leader in gene delivery solutions – has announced the construction of a new R&D and manufacturing center in Guangzhou, China. The ‘Gene Delivery Research and ...
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China. VectorBuilder, a global gene delivery solutions company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback